Records containing: Tardive Dyskinesia

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

All FDA submission records EMA medicine records ClinicalTrials.gov record updates ClinicalTrials.gov records with results posted

CLINICAL_TRIALS study record update · 2018-04-11
A Randomized, Double-Blind, Placebo-Controlled, Fixed-Dose Study of SD-809 (Deutetrabenazine) for the Treatment of Moderate to Severe Tardive Dyskinesia
CLINICAL_TRIALS study record update · 2018-03-20
A Randomized, Double-Blind, Placebo-Controlled Study of SD-809 (Deutetrabenazine) for the Treatment of Moderate to Severe Tardive Dyskinesia
CLINICAL_TRIALS study record update · 2018-02-26
Repetitive Transcranial Magnetic Stimulation for the Treatment of the Tardive Dyskinesia.
CLINICAL_TRIALS study record update · 2017-11-22
Real-World Evaluation Screening Study and Registry of Dyskinesia in Patients Taking Antipsychotic Agents
CLINICAL_TRIALS study record update · 2017-11-08
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder
Organize your saved records without ads with Plus.
CLINICAL_TRIALS study record update · 2017-08-10
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Titration Study to Assess the Safety, Tolerability, and Efficacy of NBI-98854 for the Treatment of Tardive Dyskinesia
CLINICAL_TRIALS study record update · 2017-08-10
A Phase 2, Double-Blind, Randomized, Placebo-Controlled, Two-Period Cross-Over Study to Evaluate the Efficacy and Safety of NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder
CLINICAL_TRIALS study record update · 2017-07-11
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel, Fixed-Dose Study to Assess the Efficacy, Safety, and Tolerability of NBI-98854 for the Treatment of Tardive Dyskinesia
CLINICAL_TRIALS study record update · 2017-05-23
Deep Brain Stimulation for Patients With Tardive Dyskinesia and or Dystonia. Efficacy and Psychiatric and Cognitive Effects
CLINICAL_TRIALS study record update · 2016-09-21
The Assessment of Movement Disorders Utilizing Live Two-Way Video
CLINICAL_TRIALS study record update · 2016-07-12
The Effect of Melatonin Treatment on Tardive Dyskinesia and Oxidative Stress: A Double-Blind Placebo-Controlled Trial
CLINICAL_TRIALS study record update · 2014-06-06
ClinicalTrials.gov study NCT00291213
CLINICAL_TRIALS study record update · 2013-07-25
Pyridoxal Kinase Activity in Schizophrenia Patients Without Versus With Tardive Dyskinesia Treated With Vitamin B6
CLINICAL_TRIALS study record update · 2012-12-12
A Placebo-controlled Cross Study of Panax Ginseng in Augmentation of Antipsychotics in 60 Partially Treatment Responsive Patients With Schizophrenia
CLINICAL_TRIALS study record update · 2011-04-20
A Phase 2, Open-Label, Dose Titration Study to Evaluate the Efficacy and Safety of NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder
CLINICAL_TRIALS study record update · 2009-11-25
Therapeutic Use of Piracetam for Treatment of Patients Suffering From Tardive Dyskinesia: a Double Blind, Placebo-Controlled Crossover Study
CLINICAL_TRIALS study record update · 2009-06-24
Tardive Dyskinesia and Cognitive Function
CLINICAL_TRIALS study record update · 2008-05-06
A Double-Blind, Randomised, Parallel-Group Comparison of Extract of Ginkgo Biloba(EGB-761) Versus Placebo as Add-on Medication in Patients With Established Tardive Dyskinesia
CLINICAL_TRIALS study record update · 2008-02-22
Randomized, Double-Blind, Placebo-Controlled Trial on the Efficacy of Omega-3 Supplementation With Docosahexaenoic Acid (DHA) on Tardive Dyskinesia